IBBQ
Invesco Nasdaq Biotechnology ETF·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
72.89MUSD
Fund Flows (1Y)
21.48MUSD
Dividend Yield
0.88%
Discount/Premium to NAV
-0.01%
Shares Outstanding
2.51M
Expense Ratio
0.19%
About Invesco Nasdaq Biotechnology ETF
Issuer
Invesco Capital Management LLC
Brand
Invesco
Inception Date
Jun 11, 2021
Structure
Open-Ended Fund
Index Tracked
NASDAQ Biotechnology Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
IBBQ provides exposure to US biotech and pharma companies that are exclusively listed on the NASDAQ Stock Market. The index includes companies classified under the biotechnology or pharmaceuticals sub sector of the Industry Classification Benchmark. Companies from any capitalization may be included, but since weighting is based on market cap, it produces a basket that heavily favors large-caps and concentrates exposure in the top names. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. IBBQ may miss opportunities in companies traded on the NYSE, which several of the other similar funds are eligible to hold. The index is rebalanced quarterly and reconstituted annually in December.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharma, Biotech & Life Sciences
Strategy
Exchange-specific
Geography
U.S.
Weighting Scheme
Market Cap
Selection Criteria
NASDAQ-listed
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +2.23% | +9.22% | +1.91% | +28.46% | +32.92% | +14.33% |
NAV Total Return | +2.54% | +9.21% | +2.54% | +30.10% | +37.19% | -0.14% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
90.62%
9.11%
0.21%
0.07%
Category
Ratio
North America
90.62%
Europe
9.11%
Asia
0.21%
Australasia
0.07%
Investment Style
No data is currently available
Top 10 Holdings
Symbol
Ratio
GILD
Gilead Sciences
9.14%
VRTX
Vertex Pharmaceuticals
9.08%
AMGN
Amgen
8.16%
REGN
Regeneron
5.88%
ALNY
Alnylam Pharmaceuticals
3.50%
INSM
Insmed
2.52%
BIIB
Biogen
1.94%
ARGX
argenx
1.87%
ILMN
Illumina
1.73%
UTHR
United Therapeutics
1.52%
Top 10 Weight 45.34%
267 Total Holdings
Is SPY better than IBBQ?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-09-22 | 2025-09-22 | 2025-09-26 | 0.096 |
| 2025-06-23 | 2025-06-23 | 2025-06-27 | 0.029 |
| 2025-03-24 | 2025-03-24 | 2025-03-28 | 0.040 |
| 2024-12-23 | 2024-12-23 | 2024-12-27 | 0.062 |
| 2024-09-23 | 2024-09-23 | 2024-09-27 | 0.089 |
| 2024-06-24 | 2024-06-24 | 2024-06-28 | 0.051 |
| 2024-03-18 | 2024-03-19 | 2024-03-22 | 0.043 |
Show more
How Much Does IBBQ Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy IBBQ?
Fund Flows
